GLP-1 weight loss in Metairie
Looking for Ozempic, Wegovy, Mounjaro, or Zepbound near New Orleans?
Aspire is a physician-supervised GLP-1 weight loss clinic in Metairie. At a free, in-person consultation, a licensed provider can discuss whether prescription medication is appropriate for you, explain how brand-name and compounded GLP-1s differ, and build a plan around your health history.*
Medically reviewed by Nauman Rashid, MD, Medical Director
Two medicines, four brand names
Semaglutide is the active ingredient in Ozempic® and Wegovy®. It acts on the GLP-1 receptor. Tirzepatide is the active ingredient in Mounjaro® and Zepbound®. It acts on both the GIP and GLP-1 receptors.
Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes. Wegovy® and Zepbound® are FDA-approved for chronic weight management.
Brand-name vs. compounded GLP-1s
A compounded medication is prepared by a pharmacy for an individual patient rather than manufactured as a brand-name product. Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or quality before they are marketed. They are not the same products as FDA-approved brand-name medicines.
A compounded medication may be considered only when appropriate for an individual patient’s medical needs and permitted under applicable law. Be cautious of any clinic that calls a compounded product “generic Ozempic” or describes it using a brand-name medicine’s FDA approval or study results.
Read the full guide: Ozempic, Wegovy, Mounjaro, and Zepbound vs. compounded GLP-1s.
Have questions about your options? Start with a free, confidential consultation.
What happens at Aspire
- A free consultation with a licensed provider at our Metairie clinic
- A review of your health history, goals, and current medications
- A clear explanation of the options available to you and their cost before you start
- In-person follow-up visits so your provider can track progress and adjust your dose
Learn more about our GLP-1 weight loss program and semaglutide weight loss in Metairie.
Questions to ask any clinic
- Is this a brand-name medication or a compounded one?
- Which pharmacy prepares it?
- Who evaluates me, and how often is my progress reviewed?
- What side effects should I watch for, and who do I call if I have them?
Frequently asked questions
Do you offer Ozempic, Wegovy, Mounjaro, or Zepbound in Metairie?
At your in-person Metairie consultation, a licensed provider can discuss whether prescription medication is appropriate for your weight-management plan. The options available to you depend on your medical needs and current prescribing and pharmacy requirements.
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Compounded medications are not FDA-approved, and they are not the same products as FDA-approved brand-name medicines such as Ozempic® or Wegovy®.
Is there a generic Ozempic or Mounjaro?
As of this writing, there is no FDA-approved generic version of semaglutide or tirzepatide in the U.S. A compounded medication is not a generic.
How much does GLP-1 weight loss cost at Aspire?
Your program begins with a free consultation. Final program pricing depends on the plan and medication your provider recommends, and it is always explained clearly before you start.
Where is your clinic?
Our one clinic is at 3445 N Causeway Blvd, Suite 900, in Metairie, convenient to New Orleans, Kenner, and The Northshore. Every evaluation and follow-up visit is in person.
Start with a free consultation
Your weight loss consultation is free. Your provider will look at your health history, explain your options honestly, and build a plan you’re comfortable with.
General information only, not individual medical advice. Ozempic®, Wegovy®, Mounjaro® and Zepbound® are trademarks of their respective owners. Aspire is not affiliated with Novo Nordisk or Eli Lilly.
* Important safety information: Compounded semaglutide and tirzepatide are prepared for individual patients by state-licensed U.S. compounding pharmacies and are not FDA-approved. They are not the same products as Ozempic®, Wegovy®, Mounjaro® or Zepbound®. GLP-1 medications are not for anyone with a personal or family history of medullary thyroid cancer or MEN 2, or who is pregnant. Common side effects include nausea, vomiting, diarrhea, and constipation. Your provider reviews your health history and current medications before prescribing.